Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 2;90(1):144-165.
doi: 10.1021/acs.analchem.7b04431. Epub 2017 Nov 21.

Cross-Linking Mass Spectrometry: An Emerging Technology for Interactomics and Structural Biology

Affiliations
Review

Cross-Linking Mass Spectrometry: An Emerging Technology for Interactomics and Structural Biology

Clinton Yu et al. Anal Chem. .

Abstract

PubMed Disclaimer

Conflict of interest statement

Competing financial interests: The authors declare no competing financial interests

Figures

Figure 1
Figure 1
The General XL-MS analysis workflow.
Figure 2
Figure 2. MS analysis workflows for MS-cleavable (A–C) and non-cleavable cross-linked peptides (D)
(A) MSn analysis of a DSSO cross-linked peptide (α-β). (B) MS2-based analysis of a DSSO cross-linked peptide with sequential CID and ETD fragmentation. (C) MS2 analysis workflow of a DSBU cross-linked peptide with HCD. (D). MS2 analysis of a DSS cross-linked peptide with HCD.
Figure 3
Figure 3. In vitro cross-linking strategies for protein complexes
(A) 1- and 2-step in-solution in vitro cross-linking protocols for protein complexes. (B) 1- and 2-step on-bead in vitro cross-linking protocols for affinity purified protein complexes. 2-step protocols in (A) and (B) involve in vitro mild FA cross-linking prior to the second cross-linking step. (C) 2-step cross-linking protocol by coupling in vivo mild FA prefixing with on-bead in vitro cross-linking of affinity purified protein complexes.
Figure 4
Figure 4. General scheme for integrative structural modeling
Integrative structural determination of the protein complexes proceeds through four main stages: (1) data is first gathered from various structural elucidation methodologies; (2) subunits are represented from high-resolution structures while other forms of low-resolution structural data are translated into spatial restraints; (3) configurational sampling produces an ensemble of structures that satisfies translated restraints; and (4) the ensemble structure is analyzed and validated. Adapted from Wang, et al (This research was originally published in J. Biol. Chem. Wang, X., Chemmama, I.E., Yu, C., Huszagh, A., Xu, Y., Viner, R., Block, S.A., Cimermancic, P., Rychnovsky, S.D., Ye, Y., Sali, A., Huang, L. The Proteasome-Interacting Ecm29 Protein Disassembles the 26S Proteasome in Response to Oxidative Stress. J Biol. Chem. 2017, 292(39):16310–16320. © the American Society for Biochemistry and Molecular Biology).
Figure 5
Figure 5. Workflows for proteome-level in vitro and in vivo QXL-MS experiments using MS-cleavable cross-linkers and MSn-based acquisition
Pair-wise QXL-MS can be carried out using (A) cross-linking labeling with isotope-coded reagents and (B) SILAC-based metabolic labeling. Cross-linked peptides are identified in MS3, while corresponding parent ions are quantified in MS1 based on their spectral abundance. (C) QMIX-based multiplexed QXL-MS strategy, in which each peptide digest is labeled with a distinct isobaric labeling reagent and then mixed equivalently prior to LC-MSn analysis. Cross-linked peptides are both identified and quantified in MS3, based on sequencing ions and quantitative reporter ions released during HCD fragmentation. Note: Reporter ions in MS3 can be significantly enhanced using synchronous precursor selection (SPS) acquisition to increase quantitation sensitivity and accuracy.

References

    1. Mendoza VL, Vachet RW. Mass Spectrom Rev. 2009;28:785–815. - PMC - PubMed
    1. Kiselar JG, Chance MR. J Mass Spectrom. 2010;45:1373–1382. - PMC - PubMed
    1. Konermann L, Pan J, Liu YH. Chemical Society reviews. 2011;40:1224–1234. - PubMed
    1. Sinz A. Mass Spectrom Rev. 2006;25:663–682. - PubMed
    1. Petrotchenko E, Borchers C. BMC bioinformatics. 2010;11:64. - PMC - PubMed

Publication types